Literature DB >> 9485115

Osteosarcoma of the larynx.

J K Berge1, S B Kapadia, E N Myers.   

Abstract

Malignant mesenchymal tumors of the larynx constitute 0.3% to 1% of all laryngeal cancers, and of these osteosarcoma is the rarest. Our review of the literature identified only 12 cases of osteosarcoma of the larynx, all of which occurred in men. Rarely, osteosarcoma of the larynx may follow radiation therapy for squamous cell carcinoma, or the larynx may be the site of metastatic osteosarcoma. We report a case of primary laryngeal osteosarcoma arising in the cricoid cartilage and the first case of osteosarcoma of the larynx occurring in a woman.

Entities:  

Mesh:

Year:  1998        PMID: 9485115     DOI: 10.1001/archotol.124.2.207

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  5 in total

Review 1.  A review of primary osteosarcoma of the larynx and case report.

Authors:  Esraa Mosalleum; Amir Afrogheh; Sacha Stofberg; Abraham Fourie Bezuidenhout; Johann Schneider; Jos Hille
Journal:  Head Neck Pathol       Date:  2014-06-20

2.  Single-cell transcriptomic landscapes of a rare human laryngeal chondrosarcoma.

Authors:  Chen Lin; Zhisen Shen; Yanguo Li; Shanshan Gu; Yaqin Lu; Hongxia Deng; Dong Ye; Qi Ding
Journal:  J Cancer Res Clin Oncol       Date:  2021-12-21       Impact factor: 4.553

3.  Osteosarcoma of the larynx: a case report.

Authors:  Giampiero Mottola; Anna Maria Cascone; Matteo Cavaliere; Basilio Angrisani; Gabriella Fiorillo; Giuseppe Parente; Fabrizio Volino; Maurizio Iemma
Journal:  Cases J       Date:  2008-12-01

4.  Osteosarcoma of the larynx.

Authors:  Piotr Sawicki; Wojciech Każmierczak; Łukasz Szylberg; Andrzej Marszałek
Journal:  Contemp Oncol (Pozn)       Date:  2015-07-08

5.  Prognostic factors for laryngeal sarcoma and nomogram development for prediction: a retrospective study based on SEER database.

Authors:  Jia Gu; Zhifan Zuo; Lei Sun; Li Li; Ning Zhao
Journal:  Ann Transl Med       Date:  2020-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.